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Abstract: 9 
This article presents a novel approach for the analysis of 13 drugs in wastewater for use in 10 
wastewater-based epidemiology (WBE) studies. Sample preparation remains one of the 11 
principal bottlenecks in modern high-throughput analysis by ultra-high-performance liquid 12 
chromatography-tandem mass spectrometry (UHPLC-MS/MS). The proposed methodology is 13 
based on the micro-extraction of small volumes (1 mL) of wastewater using a HLB 96-well 14 
microplate and both large volume injection (LVI) and post-loop mixing injection (PLM). With 15 
this configuration, the limits of quantification (LOQ) were below the reported environmental 16 
concentrations of the target compounds in wastewater. Furthermore, both the complexity of 17 
collecting, transporting and storing the wastewater sample, sample preparation time, cost and 18 
amount of solvent used are all diminished, enhancing the suitability of this methodology for 19 
future WBE studies. A new workflow is also proposed in order to create a virtual specimen 20 
library bank for WBE by using high-resolution mass spectrometry (HRMS). The method was 21 
validated and the limits of quantification were between 0.2 and 6.3 ng L-1. The relative standard 22 
deviations (RSD) for a standard mixture at 200 ng L-1 (n=6) was between 3.4 and 14.4% while 23 
the recoveries for the 13 drug target residues (DTR) were between 92 and 110%. The developed 24 
and validated method was finally successfully applied to 10 wastewater samples collected from 25 
Oslo, Norway. 26 
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2 
1. Introduction37 
Wastewater-based epidemiology (WBE) has been established as a complementary tool to 38 
estimate drug use at the population level by the quantitative measurement of endogenous and 39 
exogenous biomarkers excreted by humans in wastewater [1]. Recently WBE has also been 40 
shown to be an effective approach for estimating population level human exposure to a wide 41 
range of pollutants [2, 3]. WBE has the potential to provide real-time data on geographical and 42 
temporal trends in illicit drug use [4]. Traditional methods used for this purpose are usually 43 
based on population surveys, sales data, clinical cases, seizures or mortality rates related to use, 44 
but these approaches lack representativeness, are time consuming and expensive [5]. 45 
The WBE procedure consists of several steps involving sample collection, chemical analysis 46 
and the drug target residue (DTR) back-calculation, which are subject to a certain number of 47 
sources of uncertainty that have been described and progressively diminished by using a 48 
harmonized approach [6]. The appropriate collection of representative composite wastewater 49 
samples to compensate for the flow fluctuations during the sampling has been described by Ort 50 
and colleagues [7], presenting an acceptable uncertainty when estimating the population 51 
weighted loads of around 5 to 10% [6]. Furthermore, wastewater data has been shown to present 52 
low temporal representativeness when assessing annual averages [8]. Consequently, the annual 53 
estimates for a certain substance based on WBE studies must consist of several stratified 54 
random samples ( typically 56 samples per year for an acceptable level of sample size related 55 
uncertainty < 10% [9]) rather than only one consecutive week as most of the WBE studies, such 56 
as the European-wide monitoring for the European Monitoring Centre for Drugs and Drug 57 
Addiction (EMCDDA) [10]. However, increasing the sampling frequency to decrease the 58 
annual estimate uncertainty may therefore imply a greater activity from the wastewater 59 
treatment plant (WWTP) operators in order to collect the samples to be analyzed. Therefore, 60 
there is a need to develop more suitable and cost-effective alternatives to classic methods for 61 
the long-term monitoring of exposure and substance use at community level through WBE [8]. 62 
Sample analysis is critical to achieve reliable concentration of the DTR. The uncertainty related 63 
to the analytical variability is estimated to be up to 26% [6]. Most of the DTR are found in 64 
wastewater in the ng L-1 range and therefore a pre-concentration step is usually required [11]. 65 
Solid phase extraction (SPE) is the most common procedure for this purpose and large volumes 66 
of wastewater are necessary in order to reach the required limits of detection for determining 67 
environmental concentrations (between 50 and 1000 mL) [12]. However, the majority of the 68 
above procedures are tedious and time-consuming. Miniaturization of the sample preparation 69 
has become an alternative in modern high-throughput methods. Solid phase microextraction 70 
(SPME) differs from SPE in the ratio sorbent versus sample volume. Therefore, all the different 71 
SPME configurations are an equilibrium extraction technique since only a small portion of the 72 
analyte is extracted from the sample whereas SPE techniques are based on the complete 73 
extraction of all the analytes from the sample. Micro-SPE (µSPE) is a miniaturized version of 74 
SPE with the same concept of extracting all the analytes but in this case, with a smaller sample 75 
volume and a reduced amount of packed sorbent [13]. 76 
77 
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Large volume injection (LVI) methods are another alternative that provide the advantage of 78 
reducing sample preparation steps, improving the reproducibility and minimizing potential 79 
contamination of the sample. Furthermore, LVI increases sample throughput at minimal cost 80 
[14] and the water sample can be injected in the initial aqueous mobile phase without causing81 
serious peak broadening. However, to date, LVI methods have normally presented low82 
sensitivity with respect to the environmental levels [15], and require modern and very sensitive83 
instruments that are not always available in the analytical laboratories [16].84 
Ultra-high-performance liquid chromatography (UHPLC) has recently emerged providing 85 
higher sensitivity, better separations and improved throughput [5]. UHPLC columns are packed 86 
with much smaller particles and support greater pressures that increases the efficiency and 87 
decreases the run time. However, UHPLC columns become a problem when using LVI due to 88 
lower sample capacity leading to chromatographic distortions such as peak broadening or 89 
volume over-load issues [17]. The post-loop mixing (PLM) approach efficiently avoids the 90 
above problems by completely diluting the sample into organic mobile phase before the sample 91 
reaches the mixer and is diluted and carried to the column by the aqueous mobile phase. The 92 
initial elution solvent rate is such that the sample is retained at the head of the column in a 93 
narrow band (i.e. A:water 97%; B:methanol 3%). In this case, rather than injecting the 94 
wastewater sample directly, the sample is extracted by µSPE and then a larger volume of the 95 
eluent is injected into the system directly in organic solvent without reconstitution in water. 96 
At present the main development focus within the WBE field is based on the development of 97 
analytical methods for new markers [18-20] and reduction of the uncertainty related to both the 98 
in-sewer transformation [21] and the estimation of the population of the WWTP catchment 99 
areas [22]. However, due to the relatively low uncertainty and the inter-laboratory exercises for 100 
external quality control assurance, the analytical methods have remained unaltered, tedious and 101 
inefficient. Therefore, the combination of µSPE with PLM together with LVI provides a perfect 102 
compromise between sample throughput, cost, sensitivity and chromatographic separation.  103 
The aim of this study was to develop, validate and apply a novel high-throughput WBE 104 
procedure for the analysis of 13 DTR by off-line µSPE-PLM-LVI-UHPLC coupled to tandem 105 
mass spectrometry (MS/MS). The selected compounds were amphetamine, methamphetamine, 106 
3,4-methylenedioxymethamphetamine (MDMA), benzoylecgonine, cocaine, cocaethylene, 107 
atenolol, citalopram, carbamazepine, fexofenadine, methylphenidate, metoprolol and lidocaine. 108 
Thus, this procedure will potentially improve the technical and environmental WBE feasibility 109 
by: i) reducing sample preparation and analysis time; ii) reducing costs; iii) reducing the amount 110 
of solvents needed; iv) improving the whole method efficiency, v) making the sample collection 111 
and storage easier for the WWTP operator (from 1L to 5 mL or from one big bottle to one small 112 
glass vial) and vi) enabling the creation of a virtual specimen library bank for WBE by archiving 113 
and retrospectively analyzing the data acquired in HRMS mode. Finally, to demonstrate the 114 
feasibility of this approach, µSPE-PLM-LVI-UHPLC-MS/MS was applied to the analysis of 115 
10 wastewater samples. 116 
117 
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2. Experimental 118 
2.1 Reagents and materials. 119 
Reference standards for 13 drugs and/or their main metabolites chosen for the analysis were the 120 
following: amphetamine, methamphetamine, MDMA, cocaine, benzoylecgonine, 121 
cocaethylene, atenolol, citalopram, carbamazepine, fexofenadine, methylphenidate, 122 
metoprolol, and lidocaine dissolved in methanol (MeOH) or acetonitrile (ACN) at 123 
concentrations of 1 mg mL-1 or 100 µg mL-1. Standard solutions of each compound were made 124 
in methanol at 100 µg mL-1 and then diluted into final mix solutions to a concentration of 10 125 
and 1 ng mL-1. Corresponding isotope-labeled internal standards (ILIS) were amphetamine-d8, 126 
methamphetamine-d11, MDMA-d5, cocaine-d3, benzoylecgonine-d3, cocaethylene-d3, 127 
atenolol-d7, fexofenadine-d6, metoprolol-d7 and lidocaine-d6 dissolved in MeOH or ACN at 128 
concentrations of 100 µg mL-1. The ILIS solutions were made in methanol at 10 µg mL-1 and 129 
then diluted to a mix working solution at 10 ng mL-1. All reference standards and ILIS were 130 
purchased from Cerilliant (Round Rock, TX, USA). The standards and working solutions were 131 
stored at -20 °C.  132 
HPLC-grade MeOH was purchased from Rathburn Chemicals Ltd. (Walkerburn, SCT, UK). 133 
HPLC-grade ACN was acquired from VWR Chemicals (Oslo, Norway). Ammonium hydroxide 134 
(NH4OH) solution ≥ 25% in water was obtained from Fluka - Sigma-Aldrich (Oslo, Norway) 135 
and formic acid (FA) 98-100% (for analysis) was purchased from Merck - Millipore (Oslo, 136 
Norway). 137 
2.2 Wastewater samples 138 
Influent wastewater samples were collected from Vestfjorden Avløpselskap (VEAS), the Oslo 139 
wastewater treatment plant (WWTP) in June 2016. A total of 10 flow proportional samples 140 
were collected with an EFCON® Wall Mounted Vacuum sampler from the VEAS raw inlets 141 
between the 17th and the 30th of June. The sampler was operated at 4 °C and the wastewater 142 
samples were firstly collected in high-density polyethylene (HDPE) bottles and then 143 
homogenized, poured into the 7 mL glass vials and stored at -20 °C immediately following 144 
collection. 145 
Weekend composite samples consisted of a three-day composite sample from Friday (08:00) to 146 
Monday (08:00) while weekdays were twenty-four-hour composite samples. VEAS treats 147 
sewage for a de jour population of approximately 600,000 people of which the city contributes 148 
about 70.5% and the adjoining areas representing the other 29.5%. The total length of the sewer 149 
line is 42.3 km and the mean residence time in the sewer system is 5 hours [23]. 150 
  151 
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2.3 Sample preparation and µ-SPE  152 
Sample preparation is a crucial step to remove any matrix components that may compete with 153 
the target analytes in the ionization process during the UHPLC-MS/MS analysis. Prior to 154 
extraction, 5 mL of influent wastewater were spiked with 50 µL of the ILIS working solution 155 
to reach a concentration of 100 ng L-1. Following vortex stirring, 1 ml of sample was centrifuged 156 
at 16,200 ×g for 5 min at 4°C in a Heraeus Fresco Biofuge (Thermo Scientific, Waltham, MA, 157 
USA) and the supernatant was used for analysis. µSPE was performed using Waters Oasis HLB 158 
µElution plates, 30 µm (Milford, MA, USA). The plate was conditioned by washing and rinsing 159 
with 1 ml of MeOH and 1 ml of ultrapure water under suction. The wastewater samples were 160 
loaded onto the plate under suction and washed with 1 ml of ultrapure water. The plate was 161 
vacuum dried for 15 min. Analytes were eluted into a 96 well plate using 50 µl of 1% NH4OH 162 
in MeOH, 100 µl of MeOH and 50 µl of 1% FA in MeOH.  163 
The final 200 µl extract was divided in two LC vials for separate analysis for both target and 164 
retrospective purposes (Figure 1). No solvent evaporation or residue re-dissolution were needed 165 
before injection and therefore, the eluent consisted only of methanol. Analysis was performed 166 
by injecting 37 µl into the PLM-LVI-UHPLC-MS/MS. 167 
2.4 LC–MS/MS analysis 168 
Wastewater analysis was carried out with a Waters Acquity UPLC system (Milford, MA, USA) 169 
equipped with a binary solvent manager and a sample manager. The UHPLC was coupled to a 170 
Waters Quattro Premier XE Micromass triple quadrupole mass spectrometer (Milford, MA, 171 
USA) with a T-wave collision cell and electrospray ionization interface (ESI), operated in 172 
positive ionization mode. Selected parent and product ions together with ionization and 173 
collision energy parameters are presented in Table 1. Mass spectrometer parameters were tuned 174 
with a direct infusion of standard solutions. Information about the HRMS acquisition 175 
parameters and other information can be found in Baz-Lomba et al. 2016 [24]. 176 
Chromatographic separation was carried out using a Waters Acquity UPLC BEH C8 column, 177 
1.7 µm, 2.1 x 100 mm (Milford, MA, USA). The column temperature was kept at 50°C and the 178 
temperature of the sample manager was 4°C. A constant flow rate of 0.4 ml min-1 was used 179 
with a mobile phase consisting of 0.1% ammonium hydroxide (solvent A) and acetonitrile 180 
(solvent B). The elution gradient changed as follows: 0 min (3% B); 4.9 min (3% B); 5.1 min 181 
(40% B); 8.5 min (60% B); 9 min (95% B); 10 min (95% B); 10.5 min (3% B); 11 min (3% B). 182 
The sample injection volume was 37 µL. 183 
The cone and desolvation gas used was nitrogen with flow rates of 50 L h-1 and 800 L h-1, 184 
respectively. The collision gas used was argon with a flow rate of 0.15 mL min-1. Other 185 
operational parameters were capillary voltage, 3.2 kV; source temperature, 100 °C and 186 
desolvation temperature, 450 °C. The loop and needle volumes were 50 and 250 µL respectively 187 
and the injection mode was partial loop with needle overfill mode (PLNO). The PLNO mode 188 
provides the best partial loop accuracy, precision, and linearity and only sample and mobile 189 
phase were injected onto the column avoiding air gaps or weak wash solvent.  190 
Data acquisition was performed working in multiple reaction-monitoring mode (MRM). 191 
Infusion solutions of individual standards were prepared to optimize MS conditions and to 192 
select MS/MS transitions for both target analytes and ILIS. The best results in terms of 193 
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sensitivity were those using ESI operating in positive ionization mode, using the protonated 194 
molecule [M+H]+ as precursor ion. The most abundant product ion of each target analyte was 195 
typically used for quantification and one additional product ion was used for confirmation. 196 
Furthermore, the retention times were also compared with those from reference standards (± 197 
0.2 minutes). Each DTR was quantified using its ILIS as a surrogate internal standard, except 198 
citalopram, carbamazepine and methylphenidate for which the ILIS with the most similar 199 
retention time and chemical structures were selected. All data were acquired and processed 200 
using MassLynx v4.1 (Milford, MA, USA). 201 
2.5 Method validation 202 
Method validation was performed in terms of linearity, method quantification limits (LOQ), 203 
relative and absolute recoveries (trueness), repeatability and matrix effects. The performance 204 
of the method was evaluated following EU guidelines with minor modifications [25]. The 205 
linearity of the method was studied by analyzing standard solutions in methanol in triplicate at 206 
eight concentrations, in the range of 0.025 to 10 ng mL-1, together with the ILIS at 0.5 ng mL-207 
1. Satisfactory linearity was considered when the correlation coefficient (R2) was higher than 208 
0.99, based on relative responses (analyte peak area/ILIS peak area). The LOQs were calculated 209 
in wastewater samples with known concentrations (all compounds were present in sample) as 210 
the concentrations giving a signal-to-noise ratio (S/N) of ≥10.  211 
Relative and absolute recoveries were tested in triplicate in wastewater samples spiked at 100 212 
ng L-1. Adequate blank samples were not found since the target compounds were present in all 213 
the wastewater samples. Therefore, an additional set of three wastewater samples were analyzed 214 
by spiking only the ILIS before extraction to account for the analyte background. Relative 215 
recoveries were calculated by spiking the ILIS before the µSPE while for the absolute 216 
recoveries, meant for the assessment of the µSPE efficiency, were spiked after the extraction, 217 
right before the injection in the LC-MS/MS system. Calibration standards in solvent were used 218 
for quantification and the relative recoveries between 80% and 120% were considered 219 
satisfactory. Precision (expressed as repeatability) was assessed as the relative standard 220 
deviation (RSD) of six wastewater samples spiked at 200 ng L-1. The matrix effects that 221 
occurred during the ionization (ESI) were assessed by spiking three wastewater extracts at 1 ng 222 
mL-1 together with the respective ILIS right before analysis and comparing its responses with 223 
that for those spiked at the same concentration in mobile phase. A non-spiked wastewater 224 
sample (only with ILIS) was analyzed simultaneously to subtract its response from the spiked 225 
sample: 226 
𝑀𝑎𝑡𝑟𝑖𝑥 𝑒𝑓𝑓𝑒𝑐𝑡 (%) =  
𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑖𝑛 𝑤𝑤 𝑒𝑥𝑡𝑟𝑎𝑐𝑡 − 𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑤𝑤 𝑏𝑙𝑎𝑛𝑘
𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑖𝑛 𝑚𝑜𝑏𝑖𝑙𝑒 𝑝ℎ𝑎𝑠𝑒 
 𝑥 100   227 
  228 
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3. Results and discussion 229 
3.1 Large volume injection and post-loop mixing injection 230 
The SPE extract is commonly evaporated under a current of nitrogen and reconstituted into the 231 
initial mobile phase to improve the chromatographic separation and avoid the sample to 232 
significantly penetrate the column without an optimal retention [24]. The PLM configuration, 233 
described in Figure 2, avoids the eluent reconstitution following µSPE and chromatographic 234 
peak distortion when using LVI with UHPLC. In the PLM-LVI configuration, the position of 235 
the mixer and line A (aqueous phase) are changed in such a way that line B (organic phase, 236 
acetonitrile) goes directly to the loop in the autosampler, drags the sample and meets the 237 
aqueous phase in the mixer located right after the autosampler and before the HPLC column. 238 
At this stage, the sample is diluted in the mixer and stacked at the head of the column. 239 
Furthermore, the PLM-LVI configuration mitigates one of the main issues when using LVI with 240 
UHPLC columns related to the lower sample capacity leading into chromatographic distortions 241 
such as peak broadening or volume over-load issues. By using a high initial water ratio (i.e 242 
97%), the sample is completely diluted in water right before the UHPLC column and retained 243 
in a narrow band at the head of the column. 244 
The ratio of the organic phase versus aqueous phase will depend on the characteristics of the 245 
target compounds and becomes a critical feature in the development of the method. 246 
Optimization of the percentages of organic phase (acetonitrile) in water was achieved by 247 
comparing the peak shapes of the early-eluting compounds. The initial gradient was tested at 248 
1,2,3,4,5 and 10% of acetonitrile. If the initial ratio of acetonitrile was too high, the polar 249 
analytes could not be retained at the column head due to the strong elution strength and 250 
therefore, the peak width of the analytes increased significantly. Both the loop and tubing (from 251 
autosampler to mixer) volumes were taken into account to estimate the time to fill the loop and 252 
drag the sample into the column (approximately 60 µL). The best compromise between peak 253 
shape and total run time was found to be 3% acetonitrile in water. Using a flow rate of 0.4 mL 254 
min-1, the initial gradient was held for 5 minutes at 3% acetonitrile and once the analytes were 255 
retained at the head of the column the % acetonitrile was increased. 256 
3.2 Method validation 257 
The principal aim of this study was to prove the concept and applicability of a µSPE- PLM-258 
LVI -UHPLC-MS/MS configuration for WBE. Therefore, neither the µSPE nor the UHPLC 259 
conditions were optimized. However, all the conditions and parameters used in this study were 260 
previously developed “in-house” for validated and published methods [24, 26]. Furthermore, 261 
the analytical method used in this study has been validated through an external inter-laboratory 262 
exercise with other 27 international laboratories for some of the studied compounds (cocaine, 263 
benzoylecgonine, amphetamine, methamphetamine and MDMA), successfully meeting all the 264 
external quality control requirements [27]. 265 
The mean correlation coefficients (R2) of the calibration curves, which are higher than 0.99 266 
(Table 2) show good linearity of the method in the range of 0.025 to10 ng mL−1. The method 267 
LOQs were below 10 ng L-1 for all the compounds, ranging from 0.2 ng L-1 for carbamazepine 268 
to 6.3 ng L-1 for MDMA, being better than achieved with and SPE-UHPLC-MS/MS method on 269 
the same 16-year old MS system [26] and were below the reported environmental 270 
concentrations of the target compounds in wastewater. 271 
 272 
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The absolute recoveries for the µSPE performed with Waters Oasis HLB were satisfactory with 273 
values higher than 79% for all the compounds except for amphetamine with only a 36% 274 
recovery. Satisfactory relative recoveries were found for all the compounds, ranging from 92% 275 
for citalopram to 110% for cocaine. Precision (n=6) for spiked wastewater samples at 200 ng 276 
L-1 was satisfactory in all cases with RSD values ranged from 3.4 to 14.4%. 277 
3.3 Matrix effects 278 
Ion suppression or enhancement is commonly observed in complex environmental matrices 279 
such as wastewater as a consequence of the matrix effect, which affects sensitivity, accuracy 280 
and the evaluation of method recovery. The matrix effect observed for the target compounds 281 
dissolved in wastewater is presented in Table 2. Little or no signal suppression was observed 282 
for MDMA, citalopram, carbamazepine and metoprolol. Atenolol and fexofenadine, both co-283 
eluting at the beginning of the chromatographic run, showed a high ion suppression while the 284 
rest of the compounds showed a moderate ions suppression/enhancement (± 20%). The matrix 285 
suppression and recoveries were acceptable for the compounds for which no corresponding 286 
isotope-labelled internal standards were available. 287 
3.4 Analysis of wastewater samples 288 
The developed method was applied to the analysis of ten 24-hour flow proportional influent 289 
samples (72-hour for the weekend samples). Standard calibration curves were used to calculate 290 
the concentrations of the target compounds and injected in duplicate at the beginning and at the 291 
end of the run. Fortified “blank” samples were injected as internal quality control during the 292 
sequence.  293 
The target compounds were found in all the inlet wastewater samples with changing 294 
concentrations (Table 3). Carbamazepine showed the highest concentrations with an average 295 
(n=10) of 1200 ng L-1 while cocaethylene and metoprolol showed the lowest concentrations 296 
with an average of 9 and 7 ng L-1 respectively. Amphetamine and methamphetamine 297 
concentrations show similar levels ranging from 200 to 600 ng L-1 respectively. MDMA was 298 
the compound with the highest coefficient of variance among the 10 samples (61%) when 299 
comparing week days with the weekend due to its recreational use during the weekend in 300 
agreement with previous works [28]. Cocaine and its main metabolite, benzoylecgonine, ranged 301 
from 100 to 700 ng L-1 and show a benzoylecgonine/cocaine ratio of approximately 2~3, in 302 
agreement with previous publications [12]. For the rest of the pharmaceuticals, concentrations 303 
ranged from 25 to 48 ng L-1 for atenolol, from 35 to 71 ng L-1 for citalopram, from 117 to 205 304 
ng L-1 for fexofenadine, from 140 to 263 ng L-1 for methylphenidate and from 55 to 108 ng L-1 305 
for lidocaine. 306 
3.5 Environmental feasibilities and implications for the future 307 
In summary, the 96-well plate for µSPE provides the highest throughput for the analysis of 308 
wastewater samples to date. The main advantages are the reduction of the time invested per 309 
sample, the final cost per sample is lower (only the cartridges are approximately 25% less 310 
expensive and the amount of ILIS used compared with classic methods is approximately 100 311 
times less), slightly decrease of matrix effects due to the reduction of the volume extracted and 312 
from the environmental point of view, is more feasible due to the reduction of the solvents used 313 
for the extraction, by approximately a 90%. 314 
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Furthermore, the HLB sorbent, with a hydrophilic-lipophilic-balanced sorbent, offers the 315 
possibility to extract a wide range of compounds with different psychochemical characteristics 316 
enabling the simultaneous analysis of a wide range of drugs and pharmaceuticals in one single 317 
extraction. The use of this generic extraction methodology also is very suitable for HRMS and 318 
retrospective analysis, which have been proposed as a good alternative for data storage and 319 
environmental repository without the need of additional sample analyses [29]. Furthermore, 320 
this workflow does not imply additional extractions and both analysis are performed using the 321 
same extract. Therefore, the approach proposed in Figure 1 will allow the performance of 322 
different tasks such as pre- and post-target analysis, potential elucidation of metabolites and 323 
transformation products, retrospective analysis and non-target analysis only with one extraction 324 
and two analysis. 325 
The PLM-LVI configuration complements the µSPE reducing even more the sample 326 
preparation time by avoiding the reconstitution of the eluent. Furthermore, this configuration 327 
also improves the efficiency of the method by injecting larger volumes. Most of the published 328 
analytical methods for the analysis of wastewater samples reconstitute the eluent in 250-1000 329 
µL for a final injection of a few µL (normally between 2-5 µL) [24, 30]. In this study, we elute 330 
200 µL that are split in two for target and retrospective analysis, and 37 µL out of 100 µL are 331 
injected into the system. This configuration would also allow the introduction of robots or 332 
automated µSPE that would simplify and improve substantially the method in the future. 333 
The reduction of the time invested for collecting, extracting and analyzing the sample together 334 
with substantial reduction of the cost, increase the possibilities for the laboratories to perform 335 
real-time monitoring. The fact that the staff at the WWTP move from collecting 500-1000 ml 336 
in big plastic bottles to 5 mL in small glass vials could potentially increase the number of 337 
collaborations between laboratories and treatment plants. 338 
4. Conclusions 339 
A novel analytical methodology based on the use of µSPE-PLM-LVI-UHPLC-MS/MS has 340 
been developed for the simultaneous quantification and confirmation of 13 widely consumed 341 
drugs in urban wastewater and applied to 10 influent wastewater samples from Oslo, Norway. 342 
A high throughput analytical procedure has been fully validated, obtaining satisfactory accuracy 343 
and precision and high sensitivity. The method LOQs are comparable with previous studies and 344 
below the environmental concentrations found is Oslo during the last years.  345 
The combination of µSPE with PLM-LVI has been demonstrated to be a promising compromise 346 
to reduce the sample preparation time and still reach the required detection levels for 347 
environmental samples. Furthermore, reducing total cost and amounts of solvents, increasing 348 
the method efficiency and improving the collection and handling of the samples, have upgraded 349 
the technical and environmental feasibility of classic WBE methods. These results highlight the 350 
potential of µSPE-PLM-LVI-UHPLC-MS/MS for WBE studies in the future. 351 
In addition, a 200 µL µSPE extract is enough for both the quantitative and HRMS analysis, 352 
which will enable the creation of a virtual specimen library bank for WBE. This additional 353 
workflow will archive all the data for retrospective analysis, functioning as a backup for cases 354 
when old samples are not available or degraded.  355 
  356 
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 460 
Figure 2. Schematic representation of post-loop mixing process. Initial mobile phase rate (flow 0.5 mL 461 
min-1) is set at 97% A:3% B during the first 5 minutes in order to retain the sample at the head of the 462 
UHPLC column 463 
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Table 1. MS/MS optimized conditions for selected compounds. 465 
   Quantitation      Confirmation 
Compound ESI Retention time MRM (Q1 > Q3) Cone (V) Collision (V)   MRM (Q1 > Q3) 
Amphetamine + 6.6 136.1 > 91.1 20 15  136.1 > 119.1 
Amphetamine-d8 + 6.6 144.1 > 97.1 20 15  - 
Methamphetamine + 7.0 150.1 > 91.1 20 15  150.1 > 119.1 
Methamphetamine-d11 + 7.0 161.2 > 127.1 20 15  - 
MDMA + 6.9 194.2 > 163.2 20 15  194.2 > 105.1 
MDMA-d5 + 6.9 199.2 > 165.2 20 15  - 
Cocaine + 7.4 304.2 > 182.2 30 20  304.2 > 105 
Cocaine-d3 + 7.4 307.2 > 185.2 30 22  - 
Benzoylecgonine + 5.9 290.2 > 168.2 30 20  290.2 > 105 
Benzoylecgonine-d3 + 5.9 293.2 > 171.2 30 20  - 
Cocaethylene + 8.0 318.2 > 196.2 30 20  318.2 > 82.1 
Cocaethylene-d3 + 8.0 321.2 > 199.1 30 20  - 
Atenolol + 6.0 267.2 > 190 25 20  267.2 > 145 
Atenolol-d7 + 6.0 274 > 145 30 20  - 
Citalopram + 8.1 325.2 > 262.2 30 22  325.2 > 109.2 
Carbamazepine + 6.5 237.1 > 194.1 25 20  237.1 > 192.1 
Fexofenadine + 5.9 502.3 > 466.3 20 30  502.3 > 171.1 
Fexofenadine-d6 + 5.9 508.3 > 472.5 30 30  - 
Methylphenidate + 7.2 243.3 > 84 20 20  243.3 > 174.1 
Metoprolol + 6.7 268.2 > 116 25 20  268.2 > 191 
Metoprolol-d7  + 6.7 275.2 > 123.1 28 20  - 
Lidocaine + 7.7 235.3 > 86 25 20  235.3 > 58.1 
Lidocaine-d6  + 7.7 241.3 > 86 25 15  - 
                
 466 
  467 
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Table 2. Method performance parameters: linearity, recoveries, repeatability, matrix effect and method 468 
limits of quantification. 469 
 470 
  471 
 
MeOH ILIS used for correction
Linearity (R2) Relative recovery (RSD) Absolute recovery (RSD) Repeatability (RSD) Matrix Effects LOQ
ng mL-1  Both in % Both in % % % 
n=3 [100 ng L-1] n=3 [100 ng L-1] n=3 [200 ng L-1] n=6 n=3
Amphetamine 0.025 - 10 (0.99931) 105 (14) 36 (18) 14.4 80 3.5 Amphetamine-d8
Methamphetamine 0.025 - 10 (0.99941) 94 (10) 95 (3) 9.3 117 1.1 Methamphetamine-d11
MDMA 0.025 - 10 (0.99973) 99 (3) 86 (5) 3.5 104 6.3 MDMA-d5
Cocaine 0.025 - 10 (0.99991) 110 (8) 79 (1) 6.8 117 4.3 Cocaine-d3
Benzoylecgonine 0.025 - 10 (0.99979) 103 (5) 86 (14) 4.3 87 2.9 Benzoylecgonine-d3
Cocaethylene 0.025 - 10 (0.99997) 98 (3) 86 (1) 3.4 118 1.0 Cocaethylene-d3
Atenolol 0.025 - 10 (0.99871) 104 (12) 87 (3) 11.1 55 4.4 Atenolol-d7
Citalopram 0.025 - 10 (0.99984) 92 (10) 87 (7) 11.3 96 1.1 Cocaethylene-d3
Carbamazepine 0.025 - 10 (0.99937) 104 (9) 93 (15) 11.3 102 0.2 Metoprolol-d7 
Fexofenadine 0.025 - 10 (0.99980) 96 (8) 90 (12) 8.8 21 5.6 Fexofenadine-d6
Methylphenidate 0.025 - 10 (0.99979) 105 (7) 91 (11) 4.9 78 1.9 Cocaine-d3
Metoprolol 0.025 - 10 (0.99954) 109 (16) 94 (3) 12.6 104 2.1 Metoprolol-d7 
Lidocaine 0.025 - 10 (0.99989) 100 (3) 92 (5) 3.6 113 0.3 Lidocaine-d6 
Wastewater
ng L-1  
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Table 3. Concentrations of the target compounds quantified in 10 wastewater samples from Oslo in 472 
2016 (ng L-1). 473 
 474 
 475 
17-19/06/16 20/06/16 21/06/16 22/06/16 23/06/16 24-26/06/16 27/06/16 28/06/16 29/06/16 30/06/16
Weekend Monday Tuesday Wednesday Thursday Weekend Monday Tuesday Wednesday Thursday
Amphetamine 459 282 227 372 426 594 393 372 402 349
Methamphetamine 447 300 250 375 398 480 386 353 395 354
MDMA 117 61 28 45 44 145 78 44 38 35
Benzoylecgonine 644 340 236 405 535 718 495 420 456 371
Cocaine 300 119 108 195 257 306 187 194 195 176
Cocaethylene 16 6 4 7 10 16 9 8 9 8
Atenolol 42 30 25 39 44 38 33 43 48 32
Citalopram 65 58 35 60 66 59 58 66 71 55
Carbamazepine 1379 1241 888 1315 1433 1277 1168 1200 1389 1091
Fexofenadine 205 165 117 167 178 182 142 166 165 165
Methylphenidate 185 167 140 205 263 204 215 232 232 177
Metoprolol 6 5 3 7 10 9 7 7 7 5
Lidocaine 89 87 55 71 85 83 72 77 108 78
                             Date                              
Compound
Wastewater Concentration (ng/L)
